690 related articles for article (PubMed ID: 9040461)
81. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
Niederkorn JY; Streilein JW
J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
[TBL] [Abstract][Full Text] [Related]
82. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties.
Wilbanks GA; Streilein JW
Reg Immunol; 1992; 4(3):130-7. PubMed ID: 1303096
[TBL] [Abstract][Full Text] [Related]
83. Abnormal anterior chamber associated immune deviation (ACAID) in 129-strain mice.
Herndon J; Gibler TS; Ferguson TA; Van Gelder RN
Ocul Immunol Inflamm; 2006 Feb; 14(1):7-12. PubMed ID: 16507485
[TBL] [Abstract][Full Text] [Related]
84. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts.
Jiang LQ; Jorquera M; Streilein JW
Exp Eye Res; 1994 Jun; 58(6):719-28. PubMed ID: 7925711
[TBL] [Abstract][Full Text] [Related]
85. Loss and restoration of immune privilege in eyes with corneal neovascularization.
Dana MR; Streilein JW
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2485-94. PubMed ID: 8933765
[TBL] [Abstract][Full Text] [Related]
86. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein.
Hara Y; Caspi RR; Wiggert B; Chan CC; Wilbanks GA; Streilein JW
J Immunol; 1992 Mar; 148(6):1685-92. PubMed ID: 1531843
[TBL] [Abstract][Full Text] [Related]
87. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
Farooq SM; Ashour HM
Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
[TBL] [Abstract][Full Text] [Related]
88. GATA-3 expression in the development of anterior chamber associated immune deviation.
Fu T; Yang PZ; Huang XK; Huang Q; Zhou HY; Li B; Zhong HH; Chen X
Chin Med J (Engl); 2005 Dec; 118(23):2000-4. PubMed ID: 16336837
[TBL] [Abstract][Full Text] [Related]
89. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena.
Holda JH; Maier T; Claman HN
J Immunol; 1985 Mar; 134(3):1397-402. PubMed ID: 3155767
[TBL] [Abstract][Full Text] [Related]
90. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.
Zhang Y; Zhang M; Zhao S; Li X; Jia Z; Zhang L; Han ZC; Zhang X
Int Immunopharmacol; 2013 Jan; 15(1):114-20. PubMed ID: 23178576
[TBL] [Abstract][Full Text] [Related]
91. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
92. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
[TBL] [Abstract][Full Text] [Related]
93. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
Hori J; Joyce N; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):443-52. PubMed ID: 10670474
[TBL] [Abstract][Full Text] [Related]
94. Intracameral injection of antigen potentiates the production of antigen-specific T cell proteins in serum after the induction of delayed-type hypersensitivity.
Hadjikouti CA; Wang Y; O'Rourke J; Cone RE
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1470-6. PubMed ID: 7775125
[TBL] [Abstract][Full Text] [Related]
95. Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.
Benson JL; Niederkorn JY
Immunology; 1992 Oct; 77(2):189-95. PubMed ID: 1427974
[TBL] [Abstract][Full Text] [Related]
96. Th1/Th2-balance in anterior chamber-associated immune deviation by alloantigen.
Sakai R; Yamagami S; Inoki T; Tsuru T; Kawashima H
Graefes Arch Clin Exp Ophthalmol; 2002 Feb; 240(2):154-9. PubMed ID: 11931082
[TBL] [Abstract][Full Text] [Related]
97. The immune response and the eye. II. The nature of T suppressor cell induction in anterior chamber-associated immune deviation (ACAID).
Ferguson TA; Waldrep JC; Kaplan HJ
J Immunol; 1987 Jul; 139(2):352-7. PubMed ID: 2955039
[TBL] [Abstract][Full Text] [Related]
98. Lymphoma allografts abrogate immune privilege within the anterior chamber of the eye.
Niederkorn JY; Streilein JW
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1235-43. PubMed ID: 3089965
[TBL] [Abstract][Full Text] [Related]
99. Abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells.
Sano S; Suda T; Qian JH; Sato S; Ikegami R; Hamaoka T; Fujiwara H
J Immunol; 1987 Dec; 139(11):3652-9. PubMed ID: 3680947
[TBL] [Abstract][Full Text] [Related]
100. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta.
Wilbanks GA; Streilein JW
Eur J Immunol; 1992 Apr; 22(4):1031-6. PubMed ID: 1551403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
